Evidence map›Paper›PMID 28225803›Full record

ArticlePloS one2017

Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide.

Arpan Deb, William A Johnson, Alexander P Kline, Boston J Scott, Lydia R Meador, Dustin Srinivas, Jose M Martin-Garcia, Katerina Dörner, Chad R Borges, Rajeev Misra and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Highly Expressed Soluble Recombinant Anti-GFP VHHs inFrontiers in molecular biosciences · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Arpan DebSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
William A JohnsonSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Alexander P KlineSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Boston J ScottSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Lydia R MeadorSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Dustin SrinivasSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Jose M Martin-GarciaSchool of Molecular Sciences, Arizona State University, Tempe, Arizona, United States of America.
Katerina DörnerSchool of Molecular Sciences, Arizona State University, Tempe, Arizona, United States of America.
Chad R BorgesSchool of Molecular Sciences, Arizona State University, Tempe, Arizona, United States of America.
Rajeev MisraSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Brenda G HogueSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.
Petra FrommeSchool of Molecular Sciences, Arizona State University, Tempe, Arizona, United States of America.
Tsafrir S MorSchool of Life Sciences, Arizona State University, Tempe, Arizona, United States of America.ORCID http://orcid.org/0000-0002-6123-6194
Arizona State University · US

Funding

Center for the Rational Design of Membrane Protein CrystallographyU54GM094599 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI FROMME, PETRA · 2010 to 2014
$6.8M
TARGETING AND ASSEMBLY OF E COLI OUTER MEMBRANE PROTEINSR01GM048167 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI MISRA, RAJEEV · 1997 to 2011
$2.4M
NIGMS NIH HHS R01 GM048167NIGMS NIH HHS U54 GM094599
6 · The paper itself

Abstract

Viral protein U (Vpu) is a type-III integral membrane protein encoded by Human Immunodeficiency Virus-1 (HIV- 1). It is expressed in infected host cells and plays several roles in viral progeny escape from infected cells, including down-regulation of CD4 receptors. But key structure/function questions remain regarding the mechanisms by which the Vpu protein contributes to HIV-1 pathogenesis. Here we describe expression of Vpu in bacteria, its purification and characterization. We report the successful expression of PelB-Vpu in Escherichia coli using the leader peptide pectate lyase B (PelB) from Erwinia carotovora. The protein was detergent extractable and could be isolated in a very pure form. We demonstrate that the PelB signal peptide successfully targets Vpu to the cell membranes and inserts it as a type I membrane protein. PelB-Vpu was biophysically characterized by circular dichroism and dynamic light scattering experiments and was shown to be an excellent candidate for elucidating structural models.

Indexed as

Cloning, MolecularEscherichia coliGene ExpressionHuman Immunodeficiency Virus ProteinsHumansProtein FoldingProtein Sorting SignalsViral Regulatory and Accessory ProteinsViroporin ProteinsHuman Immunodeficiency Virus ProteinsProtein Sorting SignalsViral Regulatory and Accessory ProteinsViroporin Proteinsvpu protein, Human immunodeficiency virus 1

Identifiers

PMID28225803
PMCPMC5321405
OpenAlexW2589312099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.